Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2006 3
2007 2
2008 2
2009 2
2010 4
2011 6
2012 4
2013 8
2014 7
2015 4
2016 5
2017 13
2018 4
2019 10
2020 12
2021 11
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Genomics of Adverse Drug Reactions.
Alfirevic A, Pirmohamed M. Alfirevic A, et al. Trends Pharmacol Sci. 2017 Jan;38(1):100-109. doi: 10.1016/j.tips.2016.11.003. Epub 2016 Dec 10. Trends Pharmacol Sci. 2017. PMID: 27955861 Review.
Pharmacogenetics and statin-related myopathy: what do we know?
Turner RM, Radman I, Bozina N, Alfirevic A. Turner RM, et al. Among authors: alfirevic a. Pharmacogenomics. 2020 Aug;21(12):821-825. doi: 10.2217/pgs-2020-0041. Epub 2020 Jul 29. Pharmacogenomics. 2020. PMID: 32723135 No abstract available.
Systematic review of preterm birth multi-omic biomarker studies.
Gupta JK, Alfirevic A. Gupta JK, et al. Among authors: alfirevic a. Expert Rev Mol Med. 2022 Apr 5;24:1-24. doi: 10.1017/erm.2022.13. Online ahead of print. Expert Rev Mol Med. 2022. PMID: 35379367 Free PMC article. Review.
Safety pharmacology--current and emerging concepts.
Hamdam J, Sethu S, Smith T, Alfirevic A, Alhaidari M, Atkinson J, Ayala M, Box H, Cross M, Delaunois A, Dermody A, Govindappa K, Guillon JM, Jenkins R, Kenna G, Lemmer B, Meecham K, Olayanju A, Pestel S, Rothfuss A, Sidaway J, Sison-Young R, Smith E, Stebbings R, Tingle Y, Valentin JP, Williams A, Williams D, Park K, Goldring C. Hamdam J, et al. Among authors: alfirevic a. Toxicol Appl Pharmacol. 2013 Dec 1;273(2):229-41. doi: 10.1016/j.taap.2013.04.039. Epub 2013 Jun 1. Toxicol Appl Pharmacol. 2013. PMID: 23732082 Review.
Safety perspectives on presently considered drugs for the treatment of COVID-19.
Penman SL, Kiy RT, Jensen RL, Beoku-Betts C, Alfirevic A, Back D, Khoo SH, Owen A, Pirmohamed M, Park BK, Meng X, Goldring CE, Chadwick AE. Penman SL, et al. Among authors: alfirevic a. Br J Pharmacol. 2020 Oct;177(19):4353-4374. doi: 10.1111/bph.15204. Epub 2020 Aug 13. Br J Pharmacol. 2020. PMID: 32681537 Free PMC article. Review.
Characterization of Clozapine-Responsive Human T Cells.
Ogese MO, Lister A, Jenkins RE, Meng X, Alfirevic A, Douglas L, Mcloughlin R, Silva E, Park BK, Pirmohamed M, Naisbitt DJ. Ogese MO, et al. Among authors: alfirevic a. J Immunol. 2020 Nov 1;205(9):2375-2390. doi: 10.4049/jimmunol.2000646. Epub 2020 Sep 28. J Immunol. 2020. PMID: 32989092
Pharmacogenomics: Current State-of-the-Art.
Carr DF, Alfirevic A, Pirmohamed M. Carr DF, et al. Among authors: alfirevic a. Genes (Basel). 2014 May 26;5(2):430-43. doi: 10.3390/genes5020430. Genes (Basel). 2014. PMID: 24865298 Free PMC article.
102 results